Original Article
Author Details :
Volume : 6, Issue : 4, Year : 2023
Article Page : 81-85
https://doi.org/10.18231/j.sajhp.2023.019
Abstract
Background: Pregnancy-related hypertensive diseases are a serious hazard to world health. Identifying predictive markers is crucial for timely intervention. Serum β-HCG, known for its diverse role in pregnancy, is explored due to its potential involvement in vascular remodeling and angiogenesis.
Materials and Methods: The prospective observational study involves 200 pregnant women, monitored from early gestation to delivery. Serum β-HCG levels are evaluated at different time points. Data collection includes clinical assessments, obstetric evaluations, and blood sample analysis. Statistical analysis is conducted using MedCalc software.
Results: Among 200 cases, elevated serum β-HCG levels (≥2 MoM) show a higher prevalence of hypertensive disorders (HDOP) compared to lower levels (<2 MoM). Maternal and fetal outcomes are explored, revealing adverse outcomes associated with elevated β-HCG levels. Age, religion, and parity distributions are analyzed for their correlation with HDOP.
Conclusion: The study establishes a strong correlation between the onset of HDOP and increased β-HCG levels. There is no discernible relationship between age and HDOP, while religious variations and parity suggest potential relationships. The study also highlights a significant link between proteinuria and HDOP. For a thorough understanding, more studies with bigger sample numbers and controlled designs are advised.
How to cite : Rathor P, Inani A, Vashisth P, Investigating the function of serum B-HCG levels in the prognosis of hypertensive pregnancy disorders: A prospective observational study. South Asian J Health Prof 2023;6(4):81-85
This is an Open Access (OA) journal, and articles are distributed under the terms of the Creative Commons Attribution-NonCommercial-ShareAlike 4.0 License, which allows others to remix, tweak, and build upon the work non-commercially, as long as appropriate credit is given and the new creations are licensed under the identical terms.
Received : 13-11-2023
Accepted : 29-11-2023
Viewed: 518
PDF Downloaded: 181